Renal Cell Carcinoma
📧 Sign up to get email alerts when something new happens for Renal Cell Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-11-24Clinical Trial Update: Pembrolizumab and Lenvatinib in Patients With Brain Metastases From Melanoma or Renal Cell Carcinoma [Phase 2]
Phase 2 trial of pembrolizumab plus lenvatinib for brain metastases from melanoma or renal cell carcinoma has been terminated; the update no…
-
CLINICAL_TRIALS trial_result · 2025-11-18Clinical Trial Update: Evaluation of Hemostatic Agents in Partial Nephrectomy [NA]
A completed clinical trial evaluating hemostatic agents used during partial nephrectomy to assess bleeding control in localized renal cell c…
-
CLINICAL_TRIALS trial_result · 2025-11-12Clinical Trial Update: Ph2 Study NKT2152 With Palbociclib & Sasanlimab in Subjects With Advanced Clear Cell Renal Cell Carcinoma (ccRcc) [Phase 2]
Phase 2 study evaluating NKT2152 in combination with palbociclib and sasanlimab for advanced clear cell renal cell carcinoma has been termin…
-
CLINICAL_TRIALS trial_result · 2025-11-12Clinical Trial Update: PROMOTE: Identifying Predictive Markers of Response for Genitourinary Cancer [NA]
PROMOTE is a UCSF-sponsored clinical trial aiming to identify predictive markers of response in genitourinary cancers, including prostate ca…
-
CLINICAL_TRIALS trial_result · 2025-11-10Clinical Trial Update: A Pilot Study of Blood-based Biomarkers for Response to Immune Checkpoint Inhibitors
A pilot clinical trial update evaluating blood-based biomarkers to predict response to immune checkpoint inhibitors in non-small cell lung c…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-11-10Clinical Trial Update: Dynamic Contrast Enhancement Computed Tomography for Evaluating Tumor Perfusion in Patients With Metastatic Renal Cell Carcinoma Receiving Targeted Therapies: Renal Cell Carcinoma (RCC) Scramble [Phase 3]
Phase 3 clinical trial update evaluating dynamic contrast-enhanced CT to evaluate tumor perfusion in metastatic renal cell carcinoma patient…
-
CLINICAL_TRIALS trial_result · 2025-11-06Clinical Trial Update: Real-World Outcomes of Nivolumab+Ipilimumab and Pembrolizumab+Lenvatinib Among US Advanced Renal Cell Carcinoma (aRCC) Patients
A clinical trial update reporting real-world outcomes of two combination therapies—nivolumab+ipilimumab and pembrolizumab+lenvatinib—in US p…
-
CLINICAL_TRIALS trial_result · 2025-10-30Clinical Trial Update: A Study of APX005M in Combination With Nivolumab and Ipilimumab in Treatment Naïve Patients With Advanced Melanoma or Renal Cell Carcinoma (RCC) [Phase 1]
Phase 1 study evaluating APX005M in combination with nivolumab and ipilimumab in treatment-naïve patients with advanced melanoma or renal ce…
-
CLINICAL_TRIALS trial_result · 2025-10-29Clinical Trial Update: Study of Nivolumab and Axitinib in Patients With Advanced Renal Cell Carcinoma [Phase 1, Phase 2]
Phase 1/2 clinical trial update evaluating the combination of nivolumab and axitinib in patients with advanced renal cell carcinoma.
-
CLINICAL_TRIALS trial_result · 2025-10-22Clinical Trial Update: A Study of HFB301001 in Adult Patients With Advanced Solid Tumors [Phase 1]
The Phase 1 trial of HFB301001 in adults with advanced solid tumors has been terminated.
-
CLINICAL_TRIALS trial_result · 2025-10-20Clinical Trial Update: Study of PULSAR-ICI +/- IMSA101 in Patients With Oligometastatic NSCLC and RCC [Phase 2]
A Phase 2 study of PULSAR-ICI with or without IMSA101 in patients with oligometastatic non-small cell lung cancer and renal cell carcinoma w…
-
CLINICAL_TRIALS trial_result · 2025-10-14Clinical Trial Update: A Study of MGC018 in Combination With MGD019 in Participants With Advanced Solid Tumors [Phase 1]
This Phase 1 trial update reports on the combination of MGC018 and MGD019 in participants with advanced solid tumors, including castration-r…
-
CLINICAL_TRIALS trial_result · 2025-10-10Clinical Trial Update: A Study to Compare Treatments for a Type of Kidney Cancer Called TFE/Translocation Renal Cell Carcinoma (tRCC) [Phase 2]
Phase 2 trial comparing treatments for translocation renal cell carcinoma (tRCC), including metastatic, unresectable, and AJCC Stage III/IV …
-
CLINICAL_TRIALS trial_result · 2025-09-26Clinical Trial Update: Randomized Phase-II Study of Nivolumab Plus Ipilimumab vs. Standard of Care in Untreated and Advanced Non-clear Cell RCC [Phase 2]
A randomized Phase II trial comparing nivolumab plus ipilimumab to standard of care in untreated and advanced non-clear cell renal cell carc…
-
CLINICAL_TRIALS trial_result · 2025-09-17Clinical Trial Update: A Study of PF-07820435 as a Single Agent and in Combination in Participants With Advanced Solid Tumors [Phase 1]
Pfizer's PF-07820435 study in advanced solid tumors, including non-small-cell lung cancer and other indications, has been terminated at Phas…
-
CLINICAL_TRIALS trial_result · 2025-09-11Clinical Trial Update: Retrospective Study on the Safety of Nivolumab in Patients With mRCC and Renal Failure
This clinical trial update provides a retrospective assessment of the safety of nivolumab in patients with metastatic renal cell carcinoma a…
-
CLINICAL_TRIALS trial_result · 2025-09-10Clinical Trial Update: Study of Cabozantinib in Combination With Nivolumab and Ipilimumab in Patients With Previously Untreated Advanced or Metastatic Renal Cell Carcinoma [Phase 3]
Phase 3 study evaluating cabozantinib in combination with nivolumab and ipilimumab for previously untreated advanced or metastatic renal cel…
-
CLINICAL_TRIALS trial_result · 2025-09-08Clinical Trial Update: Fecal Microbiota Transplantation to Improve Efficacy of Immune Checkpoint Inhibitors in Renal Cell Carcinoma [Phase 1, Phase 2]
A completed Phase 1/2 clinical trial evaluating fecal microbiota transplantation to enhance the efficacy of immune checkpoint inhibitors in …
-
CLINICAL_TRIALS trial_result · 2025-09-05Clinical Trial Update: Stereotactic Radiotherapy for Renal Cancers [NA]
A completed clinical trial evaluating stereotactic radiotherapy for renal cancers, sponsored by Hospices Civils de Lyon, has finished.
-
CLINICAL_TRIALS trial_result · 2025-09-03Clinical Trial Update: The Pharmacological Effects of Using Cabozantinib With a Light Breakfast [Phase 2]
Phase 2 pharmacology study evaluating the effects of taking cabozantinib with a light breakfast in patients with renal cell carcinoma; compl…
-
CLINICAL_TRIALS trial_result · 2025-08-24Clinical Trial Update: Study of ST-1898 in Advanced Renal Cell Carcinoma [Phase 1, Phase 2]
Clinical trial update for ST-1898 in advanced renal cell carcinoma, currently in Phase 1/Phase 2 and not recruiting.
-
CLINICAL_TRIALS trial_result · 2025-08-17Clinical Trial Update: Impact of Therapeutic Patient Education on the Toxicity of Immune Checkpoint Inhibitors in Oncology [NA]
A completed clinical trial evaluating whether therapeutic patient education can reduce the toxicity associated with immune checkpoint inhibi…
-
CLINICAL_TRIALS trial_result · 2025-08-15Clinical Trial Update: A Study of SNS-101 (Anti VISTA) Monotherapy and in Combination With Cemiplimab in Patients With Advanced Solid Tumors [Phase 1, Phase 2]
A clinical trial update for SNS-101 (anti-VISTA) as monotherapy and in combination with cemiplimab in adults with advanced solid tumors, cur…
-
CLINICAL_TRIALS trial_result · 2025-08-12Clinical Trial Update: Computed Tomography Radiomics-Derived Nomogram for Predicting Early Renal Function Decline After Partial Nephrectomy in Renal Cell Carcinoma: A Multicenter Development/Validation Study
A multicenter development/validation study constructs and tests a CT radiomics-derived nomogram to predict early renal function decline afte…
-
CLINICAL_TRIALS trial_result · 2025-08-08Clinical Trial Update: Evaluation of Cabozantinib in Metastatic Renal Cell Carcinoma (mRCC) With Brain Metastases [Phase 2]
Phase 2 trial evaluating cabozantinib in metastatic renal cell carcinoma with brain metastases has completed.